Closing in on the amyloid cascade: Recent insights into the cell biology of Alzheimer's disease

Molecular Neurobiology

Volumn 22, Issue 1-3, 2001, Pages 81-98

  Huse, J T ^a   Doms, R W ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Alzheimer's disease; Amyloid ; BACE; PS1; PS2; secretase; secretase

Indexed keywords

AMYLOID; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; ASPARTIC PROTEINASE; BETA SECRETASE; GAMMA SECRETASE; PRESENILIN 1; PROTEIN BACE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AMYLOIDOSIS; ARTICLE; CHROMOSOME 21; CYTOLOGY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; NEUROPATHOLOGY; PATHOGENESIS; PROTEIN DEGRADATION; PROTEIN PROCESSING;

EID: 0034966403     PISSN: 08937648     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (158)

1. Translating cell biology into therapeutic advances in Alzheimer's disease
2. Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein
3. Structural alterations in the peptide backbone of β-amyloid core protein may account for its deposition and stability in Alzheimer's disease
4. Visualization of Aβ 42(43) and Aβ 40 in senile plaques with end-specific Aβ monoclonals: Evidence that an initially deposited species is Aβ 42(43)
5. Solution structures of β peptide and its constituent fragments: Relation to amyloid deposition
6. The carboxy terminus of the β amyloid protein is critical for the seeding of amyloid formation: Implications for the pathogenesis of Alzheimer's disease
7. Amino-terminal deletions enhance aggregation of β-amyloid peptides in vitro
8. Presenilin 1 facilitates the constitutive turnover of β-catenin: Differential activity of Alzheimer's disease-linked PS1 mutants in the β-catenin-signaling pathway
9. Cell biology of the amyloid β-protein precursor and the mechanism of Alzheimer's disease
10. The regulation of amyloid β protein precursor secretion and its modulatory role in cell adhesion
11. Amyloid β-protein precursor is associated with extracellular matrix
12. β Amyloid precursor protein mediates neuronal cell-cell and cell-surface adhesion
13. An antibody to β amyloid and the amyloid precursor protein inhibits cell-substratum adhesion in many mammalian cell types
14. A heparin-binding domain in the amyloid protein precursor of Alzheimer's disease is involved in the regulation of neurite outgrowth
15. The amyloid protein precursor of Alzheimer's disease is a mediator of the effects of nerve growth factor on neurite outgrowth
16. Cell-surface β-amyloid precursor protein stimulates neurite outgrowth of hippocampal neurons in an isoform-dependent manner
17. The β-amyloid precursor protein of Alzheimer's disease enhances neuron viability and modulates neuronal polarity
18. Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the β-amyloid precursor protein
19. Secreted form of amyloid β protein precursor is involved in the growth regulation of fibroblasts
20. From differentiation to proliferation: The secretory amyloid precursor protein as a local mediator of growth in thyroid epithelial cells
21. β-Amyloid precursor protein-deficient mice show reactive gliosis and decreased locomotor activity
22. The secreted form of the Alzheimer's amyloid precursor protein with the Kunitz domain in protease nexin-II
23. Protease nexin-II, a potent antichymotrypsin, shows identity to amyloid β-protein precursor
24. The protease inhibitory properties of the Alzheimer's β-amyloid precursor protein
25. Amyloid β-peptide is produced by cultured cells during normal metabolism
26. Production of the Alzheimer amyloid β protein by normal proteolytic processing
27. Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids
28. Targeting of cell-surface β-amyloid precursor protein to lysosomes: Alternative processing into amyloid bearing fragments
29. Evidence that production and release of amyloid β-protein involves the endocytic pathway
30. The Swedish mutation causes early-onset Alzheimer's disease by β-secretase cleavage within the secretory pathway
31. Metabolism of the "Swedish" amyloid precursor protein variant in neuro2a (N2a) cells
32. Generation of Alzheimer β-amyloid protein in the trans-golgi network in the apparent absence of vescicle formation
33. Novel β-secretase cleavage of β-amyloid precursor protein in the endoplasmic reticulum/intermediate compartment of NT2N cells
34. Alzheimer's Aβ(1-42) is generated in the endoplasmic reticulum/intermediate compartment of NT2N cells
35. Distinct sites of intracellular production for Alzheimer's disease Aβ40/42 amyloid peptides
36. Detection of a novel intraneuronal pool of insoluble amyloid β protein that accumulates with time in culture
37. Cleavage of amyloid β peptide during constitutive processing of its precursor
38. Protein kinase C-dependent α-secretase competes with β-secretase for cleavage of amyloid-β precursor protein in the trans-golgi network
39. Evidence that tumor necrosis factor α converting enzyme is involved in regulated α-secretase cleavage of the Alzheimer's amyloid protein precursor
40. Constitutive adn regulated α-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloproteinase
41. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
42. Down patients: Extracellular preamyloid deposits precede neuritic degeneration and senile plaques
43. The pattern of acquisition of plaques and tangles in the brains of patients under 50 years of age with Down's syndrome
44. Age-related changes in the density and morphology of plaques and neurofibrillary tangles in Down syndrome brain
45. Expression of the Alzheimer amyloid precursor gene transcripts in the human brain
46. Genetic risk factors in Alzheimer's disease
47. Amyloid, the presenilins and Alzheimer's disease
48. Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production
49. Early-onset Alzheimer's disease caused by mutations at codon 717 of the β-amyloid precursor protein gene
50. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease
51. A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease
52. An increased percentage of long amyloid β protein secreted by familial amyloid β protein precursor (β APP717) mutants
53. Identification of a novel aspartic protease (Asp 2) as β-secretase
54. Purification and cloning of amyloid precursor protein β-secretase from human brain
55. β-Secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE
56. Membrane-anchored aspartyl protease with Alzheimer's disease β-secretase activity
57. Human aspartic protease memapsin 2 cleaves the β-secretase site of β-amyloid precursor protein
58. Amyloid plaque core protein in Alzheimer disease and Down syndrome
59. Neuronal origin of a cerebral amyloid: Neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid plaque cores and blood vessels
60. Amyloid of neurofibrillary tangles of Guamanian parkinsonism-dementia and Alzheimer disease share identical amino acid sequence
61. Generation and regulation of β-amyloid peptide variants by neurons
62. Inhibition of amyloid β-protein production in neural cells by the serine protease inhibitor AEBSF
63. Secretion of β-amyloid precursor protein cleaved at the amino terminus of the β-amyloid peptide
64. β-Amyloid peptide and a 3-kDa fragment are derived by distinct cellular mechanisms
65. Cell-type and amyloid precursor protein-type specific inhibition of Aβ release by bafilomycin A1, a selective inhibitor of vacuolar ATPases
66. Generation of amyloid β protein from its precursor is sequence specific
67. Maturation and pro-peptide cleavage of β-secretase
68. Maturation and endosomal targeting of β-site amyloid precursor protein-cleaving enzyme: The Alzheimer's disease β-secretase
69. Characterization of Alzheimer's β-secretase protein BACE
70. A furin-like convertase mediates propeptide cleavage of BACE, the Alzheimer's β-secretase
71. Structure of the protease domain of memapsin 2 (β-secretase) complexed with inhibitor
72. Modeling of substrate specificity of the Alzheimer's disease amyloid precursor protein β-secretase
73. The gene encoding DRAP (BACE2), a glycosylated transmembrane protein of the aspartic protease family, maps to the down critical region
74. Expression analysis of BACE2 in brain and peripheral tissues
75. A new aspartyl protease on 21q22.3, BACE2, is highly similar to Alzheimer's amyloid precursor protein β-secretase
76. BACE2, a β-secretase homolog, cleaves at the β site and within the amyloid-β region of the amyloid-β precursor protein
77. Candidate gene for the chromosome 1 familial Alzheimer's disease locus
78. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene
79. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
80. Protein topology of presenilin 1
81. Membrane topology of the C. elegans SEL-12 presenilin
82. Phosphorylation, subcellular localization, and membrane orientation of the Alzheimer's disease-associated presenilins
83. The seven-transmembrane spanning topography of the Alzheimer disease-related presenilin proteins in the plasma membranes of cultured cells
84. Evidence for a six-transmembrane domain structure of presenilin 1
85. Additional evidence for an eight-transmembrane-domain topology for Caenorhabditis elegans and human presenilins
86. Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo
87. Endoproteolytic cleavage and proteosomal degradation of presenilin 2 in transfected cells
88. The proteolytic fragments of the Alzheimer's disease-associated presenilin-1 form heterodimers and occur as a 100-150-kDa molecular mass complex
89. The presenilin 1 protein is a component of a high molecular weight intracellular complex that contains β-catenin
90. Evidence that levels of presenilins (PS1 and PS2) are coordinately regulated by competition for limiting cellular factors
91. Endoproteolytic processing and stabilization of wild-type and mutant presenilin
92. Expression of Alzheimer's disease-associated presenilin-1 is controlled by proteolytic degradation and complex formation
93. Expression and analysis of presenilin 1 in a human neuronal system: Localization in cell bodies and dendrites
94. Alzheimer-associated presenilins 1 and 2: Neuronal expression in brain and localization to intracellular membranes in mammalian cells
95. Presenilin 1 controls γ-secretase processing of amyloid precursor protein in pre-Golgi compartments of hippocampal neurons
96. Endogenous presenilin-1 targets to endocytic rather than biosynthetic compartments
97. Alzheimer presenilins in the nuclear membrane, interphase kinetochores, and centrosomes suggest a role in chromosome segregation
98. Endogenous presenilin 1 redistributes to the surface of lamellipodia upon adhesion of Jurkat cells to a collagen matrix
99. Posttranslational modification and plasma membrane localization of the Drosophila melanogaster presenilin
100. Cell surface presenilin-1 participates in the γ-secretase-like proteolysis of notch
101. Facilitation of lin-12-mediated signalling by sel-12, a Caenorhabditis elegans S182 Alzheimer's disease gene
102. Skeletal and CNS defects in presenilin-1-deficient mice
103. Presenilin is required for Notch1 and Dll1 expression in the paraxial mesoderm
104. Notch1 is essential for postimplantation development in mice
105. Notch1 is required for the coordinate segmentation of somites
106. Mice lacking both presenilin genes exhibit early embryonic patterning defects
107. Presenilin 2 deficiency causes a mild pulmonary phenotype and no changes in amyloid precursor protein processing but enhances the embryonic lethal phenotype of presenilin 1 deficiency
108. Interfering with apoptosis: Ca2+-binding protein A1G-2 and Alzheimer's disease gene ALG-3
109. Generation of anti-apoptotic presenilin-2 polypeptides by alternative transcription, proteolysis, and caspase-3 cleavage
110. Alzheimer-associated presenilin-2 confers increased sensitivity to apoptosis in PC12 cells
111. Alzheimer's PS-1 mutation perturbs calcium homoeostasis and sensitizes PC12 cells to death induced by amyloid β-peptide
112. Participation of presenilin 2 in apoptosis: Enhanced basal activity conferred by an Alzheimer mutation
113. Increased apoptosis arising from increased expression of the Alzheimer's disease-associated presenilin-2 mutation (N141I)
114. Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein
115. Effects of PS1 deficiency on membrane protein trafficking in neurons
116. Presenilin 1 interaction in the brain with a novel member of the Armadillo family
117. Calsenilin: A calcium-binding protein that interacts with the presenilins and regulates the levels of a presenilin fragment
118. 0 by Alzheimer's disease gen presenilin-1
119. Presenilin 1 associates with glycogen synthase kinase-3β and its substrate tau
120. Interaction of presenilins with the filamin family of actin-binding proteins
121. Presenilin-1 forms complexes with the cadherin/catenin cell-cell adhesion system and is recruited to intercellular and synaptic contacts
122. Presenilin 1 suppresses the function of c-Jun homodimers via interaction with QM/Jif-1
123. A myristoylated calcium-binding protein that preferentially interacts with the Alzheimer's disease presenilin 2 protein
124. Familial Alzheimer's disease-linked presenilin 1 variants elevate Aβ1-42/1-40 ratio in vitro and in vivo
125. Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1
126. The E280A presenilin 1 Alzheimer mutation produces increased Aβ42 deposition and severe cerebellar pathology
127. Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease in increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease
128. Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins
129. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice
130. The presenilin 2 mutation (N141I) linked to familial Alzheimer disease (Volga German families) increases the secretion of amyloid β protein ending at the 42nd (or 43rd) residue
131. Enhanced production and oligomerization of the 42-residue amyloid β-protein by Chinese hamster ovary cells stably expressing mutant presenilins
132. Presenilin 1 mutations linked to familial Alzheimer's disease increase the intracellular levels of amyloid β-protein 1-42 and its N-terminally truncated variant(s) which are generated at distinct sites
133. Accumulation of murine amyloidβ42 in a gene-dosage-dependent manner in PS1 'knock-in' mice
134. An Alzheimer's disease-linked PS1 variant rescues the developmental abnormalities of PS1-deficient embryos
135. Mutant human presenilin 1 protects presenilin 1 null mouse against embryonic lethality and elevates Aβ1-42/43 expression
136. Total inactivation of γ-secretase activity in presenilin-deficient embryonic stem cells
137. Presenilins are required for γ-secretase cleavage of β-APP and transmembrane cleavage of Notch
138. Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and γ-secretase activity
139. The transmembrane aspartates in presenilin 1 and 2 are obligatory for γ-secretase activity and amyloid β-protein generation
140. Presenilin 1 is linked with γ-secretase activity in the detergent solubilized state
141. Presenilin complexes with the C-terminal fragments of amyloid precursor protein at the sites of amyloid β-protein generation
142. Transition-state analogue inhibitors of γ-secretase bind directly to presenilin-1
143. Photoactivated γ-secretase inhibitors directed to the active site covalently label presenilin 1
144. Signal transduction by activated mNotch: Importance of proteolytic processing and its regulation by the extracellular domain
145. Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain
146. Nuclear access and action for notch in vivo
147. A presenilin-1-dependent γ-secretase-like protease mediates release of Notch intracellular domain
148. Proteolytic release and nuclear translocation of Notch-1 are induced by presenilin-1 and impaired by pathogenic presenilin-1 mutations
149. Presenilin is required for activity and nuclear access of Notch in Drosophila
150. Separation of presenilin function in amyloid β-peptide generation and endoproteolysis of Notch
151. Tripartite management of unfolded proteins in the endoplasmic reticulum
152. A role for presenilin-1 in nuclear accumulation of Ire1 fragments and induction of the mammalian unfolded protein response
153. Presenilin-1 mutations downregulate the signalling pathway of the unfolded-protein response
154. Presenilin 1 regulates pharmacologically distinct γ-secretase activities. Implications for the role of presenilin in γ-secretase cleavage
155. Mutation of conserved aspartates affects maturation of both aspartate mutant and endogenous presenilin 1 and presenilin 2 complexes
156. Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and βAPP processing
157. Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
158. Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease